The NHS will pay billions more for drugs because of a new UK-US trade deal

The NHS will pay £3 billion more a year for life-saving medicines from giant American pharma companies, because of a new UK-US trade deal.

When big drug companies like Eli Lilly, Johnson & Johnson, Pfizer and Amgen are already making billions, and their CEOs are making tens of millions, is it right that the NHS should pay more?